4
Changes in Ownership
SELLAS Life Sciences Group, Inc. Filed Acc 0001390478-14-000030
VP, Chief Financial Officer acquired 2,461 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dunlap Ryan VP, Chief Financial Officer | 2014-06-30 | Other acquisition | +2,461 | $2.60 | $6,399 | 7,804 | D: show line 1 in the form |
Loading xslF345X03/primary_doc.xml…